Real-world utility of plasma GFAP and NfL in early-onset AD and FTD.
- DOI
- 10.1002/dad2.70490
- Published
- 2026 Jul-Sep
- Container
- Alzheimer's & dementia (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/dad2.70490,
title = {Real-world utility of plasma GFAP and NfL in early-onset AD and FTD.},
author = {Chatterjee P and Ivanic S and Southon A and McCarthy C and Patel SK and Christensen M and Darby D and Bush AI and Ayton S and Mielke MM and Werden E and Brodtmann A},
year = {2026},
journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
doi = {10.1002/dad2.70490},
url = {https://doi.org/10.1002/dad2.70490}
}RIS
TY - JOUR TI - Real-world utility of plasma GFAP and NfL in early-onset AD and FTD. AU - Chatterjee P AU - Ivanic S AU - Southon A AU - McCarthy C AU - Patel SK AU - Christensen M AU - Darby D AU - Bush AI AU - Ayton S AU - Mielke MM AU - Werden E AU - Brodtmann A PY - 2026 JO - Alzheimer's & dementia (Amsterdam, Netherlands) DO - 10.1002/dad2.70490 UR - https://doi.org/10.1002/dad2.70490 ER -
APA
P, C., S, I., A, S., C, M., SK, P., M, C., D, D., AI, B., S, A., MM, M., E, W., & A, B. (2026). Real-world utility of plasma GFAP and NfL in early-onset AD and FTD.. Alzheimer's & dementia (Amsterdam, Netherlands). https://doi.org/10.1002/dad2.70490
Source records
- pubmed · retrieved 2026-09-25T05:10:48.433Z